IMVT

NASDAQStock

Immunovant, Inc.

$24.39-0.60 (-2.42%)

52-Week Range

$13.31
$27.75

Key Stats

Market Cap

5.0B

P/E Ratio

Dividend Yield

Beta

0.63

Volume

552.3K

Avg Volume

1.1M

Performance

1M

-2.54%

3M

-3.88%

6M

+60.91%

YTD

-3.55%

1Y

+28.02%

3Y

+62.17%

5Y

+47.17%

Price Chart

ETF Exposure

IMVT is held by 98 ETFs

ETFFund NameWeight
WSMLiShares MSCI World Small-Cap ETF0.02%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.01%
SMMDiShares Russell 2500 ETF0.01%
CUS1.LiShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF0.01%
CUSS.LiShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF0.01%
FESMFIDELITY ENHANCED SMALL CAP ETF0.01%
SMLFiShares U.S. Small-Cap Equity Factor ETF0.01%
SXRG.DEiShares MSCI USA Small Cap CTB Enhanced ESG UCITS ETF0.01%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.01%
HDGProShares - Hedge Replication ETF0.01%
CBUG.DEiShares $ Treasury Bond 3-7yr UCITS ETF0.01%
USFM.LUBS MSCI USA Select Factor Mix UCITS ETF USD dis0.01%
SPGMState Street SPDR Portfolio MSCI Global Stock Market ETF0.01%
ZPRV.DEState Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF0.00%
ESGVVanguard ESG U.S. Stock ETF0.00%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
GTPEGoldman Sachs MSCI World Private Equity Return Tracker ETF0.00%
IWViShares Russell 3000 ETF0.00%
VTVanguard Total World Stock ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
V3AL.LVanguard ESG Global All Cap UCITS ETF (USD) Distributing0.00%
V3AM.LVanguard ESG Global All Cap UCITS ETF (USD) Distributing0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
DFASDimensional - US Small Cap ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TILTFlexShares Morningstar U.S. Market Factor Tilt Index Fund0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
PreviousPage 2 of 2

About IMVT ETF Exposure

Immunovant, Inc. (IMVT) is held by 98 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 5.0B, IMVT is a widely held institutional stock. The stock currently trades at $24.39. Investors can gain exposure to IMVT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold IMVT, sorted by portfolio weight.